Application of Diabetes medical treatment combination in China

Authors

  • Yuchen Zhu
  • Fengyun Jiang
  • Xingyu Zhang
  • Jingyan Jiang
  • Jianru Yao

DOI:

https://doi.org/10.61173/c0fbec49

Keywords:

Diabetes, Hierarchical diagnosis, Medical treatment combination, reversal clinic

Abstract

With the progress of the times and the development of society, opportunities and challenges coexist in contemporary society. As one of the chronic diseases with the highest prevalence rate, diabetes has brought a huge crisis to people’s daily life. Under the modern medical system, many difficult problems of diabetes patients seeking medical treatment can be solved through hierarchical diagnosis and treatment, and the pressure of outpatient service can be shared. At the same time, the use of many medical treatment combinations can make diabetes patients no longer need lifelong medication, but can replace “lifelong medication” with “lifelong management” through “diabetes reversal”. As a leading country in the treatment and prevention of diabetes using the medical treatment combination model, China has created a unique reverse outpatient model under the concept of traditional Chinese medicine. The purpose of this paper is to explore the role of medical treatment combination in promoting the treatment of diabetes from the perspective of health economy and public management mechanism.

References

[1] Ciemins, E. L., Coon, P. J., Coombs, N. C., Holloway, B. L., Mullette, E. J., & Dudley, W. N. (2018). Intent-to-treat analysis of a simultaneous multisite telehealth diabetes prevention program. BMJ Open Diabetes Research & Care, 6(1), e000515. https://doi.org/10.1136/bmjdrc-2018-000515

[2] Department of Medical Administration. (2016, August). Notice on Promoting the Pilot Work of Graded Diagnosis and Treatment. http://www.nhc.gov.cn/yzygj/s3593g/201608/7d264b 533a3b403cb8348d40cfb9a9d3.shtml

[3] Derges, J., Kidger, J., Fox, F., Campbell, R., Kaner, E., Taylor, G., McMahon, C., Reeves, L., & Hickman, M. (2017). “DrinkThink” alcohol screening and brief intervention for young people: a qualitative evaluation of training and implementation. Journal of Public Health, 40(2), 381–388. https://doi. org/10.1093/pubmed/fdx090

[4] Du, Y., Zhou, Q., Cheng, W., Zhang, Z., Hoelzer, S., Liang, Y., Xue, H., Ma, X., Sylvia, S., Tian, J., & Tang, W. (2022). Factors Influencing Adoption and Use of Telemedicine Services in Rural Areas of China: Mixed Methods Study. JMIR Public Health and Surveillance, 8(12), e40771. https://doi.org/10.2196/40771

[5] Essex, R., Kennedy, J., Miller, D., & Jameson, J. (2023). A Scoping Review Exploring the Impact and Negotiation of Hierarchy in Healthcare Organisations. Nursing Inquiry, 30(4), 1–10. https://doi.org/10.1111/nin.12571

[6] Hu, X., Meng, L., Wei, Z., Xu, H., Li, J., Li, Y., Jia, N., Li, H., Qi, X., Zeng, X., Zhang, Q., Li, J., & Liu, D. (2022). Prevalence and potential risk factors of self-reported diabetes among elderly people in China: A national cross-sectional study of 224,142 adults. Frontiers in Public Health, 10, 1051445. https://doi. org/10.3389/fpubh.2022.1051445

[7] Khan, M. M., Roberson, S., Reid, K., Jordan, M., & Odoi, A. (2021). Geographic disparities and temporal changes of diabetes prevalence and diabetes self-management education program participation in Florida. PLOS ONE, 16(7), e0254579. https:// doi.org/10.1371/journal.pone.0254579

[8] Li, C. (2021). Study on the Fairness of Diabetes Health Care in China. https://link.cnki.net/doi/10.26994/d.cnki. gdlyu.2021.000010

[9] Li, M., Zhang, X., Tang, H., Zheng, H., Long, R., Cheng, X., Cheng, H., Dong, J., Wang, X., Zhang, X., Pascal Geldsetzer, & Liu, X. (2024). Quality of primary health care for chronic diseases in low-resource settings: Evidence Dean&Francis ISSN 2959-409X from a comprehensive study in rural China. PLoS ONE, 19(7), e0304294–e0304294. https://doi.org/10.1371/journal. pone.0304294

[10] Liang, S. (2023, June 5). Diabetes in China: Burden Analysis between 1990 and 2019 and Incidence Prediction between 2020 and 2030. Https://Www.chinagp.net/ EN/10.12114/J.issn.1007-9572.2023.0009; School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. https://www.chinagp.net/ EN/10.12114/j.issn.1007-9572.2023.0009

[11] Liu, J. (2023). The incidence rate of diabetes in China has risen to more than 140 million. Cctv.com. https://news.cctv. com/2023/11/14/ARTIOKJNidhpY6xy7TKnTPha231114.shtml

[12] liu, jinli, & chai, zhonglin. (1 C.E.). Patial Distribution (a), Local Moran Analysis (b) and Hot Spot Analysis (c) of the Prevalence of Diabetes in China for 2020, 2025 and 2030. (min liu, chao li, yanan wang, mingwang shen, guihua zhang, & lei zhang, Eds.). https://pubmed.ncbi.nlm.nih. gov/36817869/#&gid=article-figures&pid=fig-1-uid-0

[13] Lu, C.-F. (2023). China on the Move: Lessons from China’s 2023 National Negotiation of Drug Prices. Natlawreview.com; National Law Review. https://natlawreview.com/article/chinamove-lessons-chinas-2023-national-negotiation-drug-prices

[14] Luo, Z., Fabre, G., & Rodwin, V. G. (2019). Meeting the Challenge of Diabetes in China. International Journal of Health Policy and Management, 9(2), 47–52. https://doi.org/10.15171/ ijhpm.2019.80

[15] Medical. (2024). On April 12, the first diabetes reversal clinic in Jiangsu Province was opened in Jiangsu Integrated Traditional Chinese and Western Medicine Hospital| Strategies | Mitigation | Yes | Reversal | diabetes | - Health sector. Cn-Healthcare.com. https://www.cn-healthcare.com/ articlewm/20220410/content-1336696.html

[16] Mou, Y., Ye, Z., Lin, M., Li, Z., & Zhu, F. (2019). Progress in Diabetes Epidemiology. Diabetes New World, 04 vo 22, 196– 198. https://doi.org/10.16658/j.cnki.1672-4062.2019.04.196

[17] Sainsbury, E., Shi, Y., Flack, J., & Colagiuri, S. (2020). The diagnosis and management of diabetes in Australia: Does the “Rule of Halves” apply?. Diabetes Research and Clinical Practice, 170, 108524. https://doi.org/10.1016/ j.diabres.2020.108524

[18] State Intellectual Property Office of China. (2022, July 16). State Intellectual Property Office of China publishes China Med Safe Tech’s patent application for parallel medicine dispensing mechanism, medicine discharging and selling machine and control method. Proquest.com. https://www. proquest.com/wire-feeds/state-intellectual-property-office-china/ docview/2690138756/se-2

[19] State Intellectual Property Office of China. (2023a, May 6). State Intellectual Property Office of China publishes Shengye Tech Changshu’s patent application for constant-temperature intelligent medicine selling machine based on image recognition system. Proquest.com. https://www.proquest.com/wire-feeds/ state-intellectual-property-office-china/docview/2811137255/ se-2

[20] State Intellectual Property Office of China. (2023b, August 23). State Intellectual Property Office of China receives Yan Ruman’s patent application for intelligent medicine purchasing method based on self-service medicine selling machine. Proquest.com. https://www.proquest.com/docview/2857749976 ?parentSessionId=ThfXIaLf%2FBdqzKFs4bpNDk7DbFXi3u4S wo2XgJ4%2FMpY%3D&sourcetype=Wire%20Feeds

[21] State Intellectual Property Office of China. (2023c, November 23). State Intellectual Property Office of China publishes Guangzhou Xiao Wecang Intelligent Drug Store Tech’s patent application for control method of multifunctional medicine selling machine. Proquest.com. https://www.proquest. com/wire-feeds/state-intellectual-property-office-china/ docview/2892180539/se-2

[22] Sun, Y., Ni, W., Yuan, X., Chi, H., & Xu, J. (2020). Prevalence, treatment, control of type 2 diabetes and the risk factors among elderly people in Shenzhen: results from the urban Chinese population. BMC Public Health, 20(1). https:// doi.org/10.1186/s12889-020-09045-1

[23] Tabata, S., Yoshimitsu, S., Hamachi, T., Abe, H., Ohnaka, K., & Kono, S. (2009). Waist circumference and insulin resistance: a cross-sectional study of Japanese men. BMC Endocrine Disorders, 9(1). https://doi.org/10.1186/1472-6823-9-1

[24] Tencent. (2023, November 14). “Lifelong medication” has changed into “lifelong management”. The first diabetes reverse clinic in Fujian has been open for half a year, and many people have benefited from it. Tencent News. Qq.com. https://new. qq.com/rain/a/20231114A05NOK00

[25] Wang, L., Gao, P., Zhang, M., Huang, Z., Zhang, D., Deng, Q., Li, Y., Zhao, Z., Qin, X., Jin, D., Zhou, M., Tang, X., Hu, Y., & Wang, L. (2017). Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA, 317(24), 2515. https:// doi.org/10.1001/jama.2017.7596

[26] Wang, Q., Zhang, X., Fang, L., Guan, Q., Guan, L., & Li, Q. (2018). Prevalence, awareness, treatment and control of diabetes mellitus among middle-aged and elderly people in a rural Chinese population: A cross-sectional study. PLOS ONE, 13(6), e0198343. https://doi.org/10.1371/journal.pone.0198343

[27] Wei, M.-H., Chen, X.-Z., Zhan, X.-X., Zhang, Z.-X., Yu, S.-J., & Yan, W.-R. (2019). The effect of a web-based training for improving primary health care providers’ knowledge about diabetes mellitus management in rural China: A pre-post intervention study. PLOS ONE, 14(9), e0222930. https://doi. org/10.1371/journal.pone.0222930

[28] World Health Organization. (2016). China country assessment report on ageing and health. Www.who.int. https:// www.who.int/publications/i/item/9789241509312

[29] Wu, H., Eggleston, K. N., Zhong, J., Hu, R., Wang, C., Xie, K., Chen, Y., Chen, X., & Yu, M. (2018). Direct medical Dean&Francis Zhu Yuchen, Jiang Fengyun, Zhang Xingyu, Jiang Jingyan, Yao Jianru cost of diabetes in rural China using electronic insurance claims data and diabetes management data. Journal of Diabetes Investigation, 10(2), 531–538. https://doi.org/10.1111/jdi.12897

[30] Xue, Y. (2019). Notice on Launching Pilot Projects for Urban Medical Consortium Construction, State Council Departmental Document, China Government Website. Www. gov.cn. https://www.gov.cn/zhengce/zhengceku/2019-10/08/ content_5437013.htm

[31] Yan, Y., Wu, T., Zhang, M., Li, C., Liu, Q., & Li, F. (2022). Prevalence, Awareness and Control of Type 2 Diabetes Mellitus and Risk Factors in Chinese Elderly Population. BMC Public Health, 22(1). https://doi.org/10.1186/s12889-022-13759-9

[32] Yang, C., Hu, S., Zhu, Y., Zhu, W., Li, Z., & Fang, Y. (2019). Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China. PLOS ONE, 14(10), e0223769. https://doi.org/10.1371/journal.pone.0223769

[33] Yao, J. (2020). The factors influencing the effect of the comunity-based type-2 diabetes mellitus management:A crosssectional study in Shandong province,China. https://link.cnki. net/doi/10.27272/d.cnki.gshdu.2020.006910

[34] Zeng, H., Zheng, R., Guo, Y., Zhang, S., Zou, X., Wang, N., Zhang, L., Tang, J., Chen, J., Wei, K., Huang, S., Wang, J., Yu, L., Zhao, D., Song, G., Chen, J., Shen, Y., Yang, X., Gu, X., & Jin, F. (2015). Cancer survival in China, 2003-2005: a populationbased study. International Journal of Cancer, 136(8), 1921–1930. https://doi.org/10.1002/ijc.29227

[35] Zhang, L., Wang, Z., Qian, D., & Ni, J. (2014). Effects of changes in health insurance reimbursement level on outpatient service utilization of rural diabetics: evidence from Jiangsu Province, China. BMC Health Services Research, 14(1). https:// doi.org/10.1186/1472-6963-14-185

[36] Zheng, W., Zheng, C., & Zhou, X. (2021). The association of GLP1R gene polymorphism with the risk of type 2 diabetes mellitus and blood glucose, serum lipids, islet function in Chinese Han population. Journal of Wenzhou Medical University, 11 vo 51, 896–901.

[37] Survey Report on Population Characteristics, Blood Glucose Monitoring and Medication Habits of Internet diabetes Patients in China 2020- Official Website of Sugar Nurses (2020). Dnurse. com. http://www.dnurse.com/v2/article/detail/26322

[38] Where did China’s nearly 130 million diabetes patients’ “sweet troubles” come from- Xinhua News Agency (2020). Xinhuanet.com. http://www.xinhuanet.com/politics/2020-11/14/ c_1126738536.htm#:~:text=%E4%BB%8E%E6%82%A3 %E7%97%85%E7%89%B9%E7%82%B9%E7%9C%8B

[39] Zhou, X., Guan, H., Zheng, L., Li, Z., Guo, X., Yang, H., Yu, S., Sun, G., Li, W., Hu, W., Guo, L., Pan, G., Xing, L., Zhang, Y., & Sun, Y. (2014). Prevalence and awareness of diabetes mellitus among a rural population in China: results from Liaoning Province. Diabetic Medicine, 32(3), 332–342. https:// doi.org/10.1111/dme.12599

[40] Zhu, Y. (2023). Guiding Opinions on Comprehensively Promoting the Construction of Close County level Medical and Health Communities _ State Council Departmental Document _ China Government Website. Www.gov.cn. https://www.gov.cn/ zhengce/zhengceku/202312/content_6923447.htm

Downloads

Published

2025-02-27